Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- FRIMPTER G. W., TIMPANELLI A. E., EISENMENGER WJ STEIN H. S., EHRLICH L. I. Reversible "Faconi syndrome" caused by degraded tetracycline. JAMA. 1963 Apr 13;184:111–113. doi: 10.1001/jama.1963.03700150065010. [DOI] [PubMed] [Google Scholar]
- Groscurth P., Kistler G. Langzeitbeobachtungen an menschlichen hypernephroiden Nierenkarzinomen in der "nude" Maus. Beitr Pathol. 1977 Aug;160(4):337–360. doi: 10.1016/s0005-8165(77)80118-2. [DOI] [PubMed] [Google Scholar]
- Hausheer F. H., Yarbro J. W. Diagnosis and treatment of malignant pleural effusion. Semin Oncol. 1985 Mar;12(1):54–75. [PubMed] [Google Scholar]
- KISTLER G. S., BISCHOFF A. [On exfoliative cytology of small quantities of fluids]. Schweiz Med Wochenschr. 1962 Jul 14;92:863–866. [PubMed] [Google Scholar]
- KOHN K. W. Mediation of divalent metal ions in the binding of tetracycline to macromolecules. Nature. 1961 Sep 16;191:1156–1158. doi: 10.1038/1911156a0. [DOI] [PubMed] [Google Scholar]
- Sahn S. A., Good J. T., Jr, Potts D. E. The pH of sclerosing agents: a determinant of pleural symphysis. Chest. 1979 Aug;76(2):198–200. doi: 10.1378/chest.76.2.198. [DOI] [PubMed] [Google Scholar]
- Sauter C., Cogoli M. Tetracycline in the treatment of malignant effusions: evidence for a cytostatic action of the decomposed drug. Eur J Cancer Clin Oncol. 1987 Jul;23(7):973–977. doi: 10.1016/0277-5379(87)90343-9. [DOI] [PubMed] [Google Scholar]
- Thomson H. J., Merani S., Miller S. S. Storage of tetracycline solutions for peritoneal lavage. J R Coll Surg Edinb. 1984 Nov;29(6):379–380. [PubMed] [Google Scholar]
- Zaloznik A. J., Oswald S. G., Langin M. Intrapleural tetracycline in malignant pleural effusions. A randomized study. Cancer. 1983 Feb 15;51(4):752–755. doi: 10.1002/1097-0142(19830215)51:4<752::aid-cncr2820510434>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]